FDA Inspection
Muckerman II, M.D., Richard C.FDA Inspection 665756 - Muckerman II, M.D., Richard C. - May 28, 2010
Record Details
This FDA Inspection record concerns Muckerman II, M.D., Richard C., with an inspection on May 28, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 28, 2010
- Product Type
- Drugs
View Company Profile
ID · ae1ce433-c7c6-4faf-bd08-894561ff6045
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 665756
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 312.60FD-1572, protocol compliance
- Procedural requirements
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.20Consent not obtained, exceptions do not apply
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Muckerman II, M.D., Richard C.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 21, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Muckerman II, M.D., Richard C.
- FDA Inspection 900461 - 2014-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.